ControlPoint Inc

Extended description

"ControlPoint Inc is an innovative animal health startup specializing in in-vitro diagnostic tests for detecting respiratory infections in companion and production animals. Utilizing multiplex microarray lateral flow tests and a mobile reader application, ControlPoint offers fast in-clinic results for identifying multiple respiratory pathogens. The company has received government funding, including an SBIR Phase I grant from the National Science Foundation for the development of their canine test. Market research studies have shown strong support from veterinarians and pet owners for ControlPoint's kennel cough test. ControlPoint is actively seeking collaborations for the development of future products, including potential partnerships with academia and industry experts in swine respiratory infections. With a focus on high margins and profitability projections, ControlPoint aims to break even within 18-24 months of revenue start-up, positioning itself as a key player in the animal diagnostics industry."